These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 4636013)

  • 1. An experimental model of secondary pulmonary hypertension.
    Gupta S; Maitra TK; Viswanathan S; Basu AK
    J Thorac Cardiovasc Surg; 1972 Dec; 64(6):953-6. PubMed ID: 4636013
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential development of lesions in experimental extreme pulmonary hypertension.
    Harley RA; Friedman PJ; Saldana M; Liebow AA; Carrington CB
    Aspen Emphysema Conf; 1968; 11():117-20. PubMed ID: 5711536
    [No Abstract]   [Full Text] [Related]  

  • 3. The experimental systemic perfused lung: histological observations in the dog.
    Manenti A; Botticelli AR; Rossi A; Giliberti G; Barbieri A; Gibertini G
    Pathologica; 1992; 84(1091):325-9. PubMed ID: 1465317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pulmonary arterial-left atrial shunt in the treatment of pulmonary hypertension. Experimental study.
    Gupta S
    J Thorac Cardiovasc Surg; 1972 Dec; 64(6):949-52. PubMed ID: 4636012
    [No Abstract]   [Full Text] [Related]  

  • 5. Single lung transplantation for canine pulmonary hypertension.
    Okada M; Yamashita C; Okada M; Nohara H; Yamagishi H; Wakiyama H; Okada K
    J Heart Lung Transplant; 1997 May; 16(5):532-7. PubMed ID: 9171272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the microcirculation of the lung after an abrupt exclusion of the pulmonary flow].
    Bertranou E; Bourassa MG; Grondin P
    Union Med Can; 1970 Dec; 99(12):2200-8. PubMed ID: 5488648
    [No Abstract]   [Full Text] [Related]  

  • 7. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
    Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
    Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary allotransplantation in dogs with chronic pulmonary hypertension.
    Weedn RJ; Guenter CA; Greenfield LJ
    Surg Forum; 1970; 21():243-5. PubMed ID: 4936974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Morphology of the lungs in dogs after the creation of an artificial shunt between the peripheral ends of the anterior (superior) vena cava and the right branch of the pulmonary artery].
    Iarygin NE; Rzhanitsin VV
    Arkh Patol; 1969; 31(9):35-41. PubMed ID: 5379996
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of experimental pulmonary hypertension by PDGF inhibition.
    Schermuly RT; Dony E; Ghofrani HA; Pullamsetti S; Savai R; Roth M; Sydykov A; Lai YJ; Weissmann N; Seeger W; Grimminger F
    J Clin Invest; 2005 Oct; 115(10):2811-21. PubMed ID: 16200212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Liu H; Liu ZY; Guan Q
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pathophysiology of pulmonary hypertension: development of a model.
    Friedman PJ; Harley RA; Liebow AA
    Adv Exp Med Biol; 1972; 22():205-50. PubMed ID: 5074642
    [No Abstract]   [Full Text] [Related]  

  • 13. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation.
    Chen EP; Bittner HB; Tull F; Biswas SS; Davis RD; Van Trigt P
    J Heart Lung Transplant; 1997 May; 16(5):538-47. PubMed ID: 9171273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic alterations in the transplanted primate lung.
    Joseph WL; Morton DL
    Surg Gynecol Obstet; 1971 Nov; 133(5):821-5. PubMed ID: 4999951
    [No Abstract]   [Full Text] [Related]  

  • 15. An experimental animal model of postobstructive pulmonary hypertension.
    Jungebluth P; Ostertag H; Macchiarini P
    J Surg Res; 2008 Jun; 147(1):75-8. PubMed ID: 18262548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on systemic pulmonary shunt with an artificial vascular prosthesis.
    Nishii T; Booka S; Umemoto H; Ishida J; Kuriyama T
    Wakayama Med Rep; 1967 Dec; 12(3):109-22. PubMed ID: 5590086
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oxygen therapy on pulmonary arterial hypertension in chronic obstructive lung disease.
    Zielinski J
    G Ital Cardiol; 1984; 14 Suppl 1():61-3. PubMed ID: 6398782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of interstitial pulmonary edema produced by venous hypertension or hemodilution in perfused lungs.
    Greenfield LJ; Reif ME; Coalson JJ; McCurdy JR; Elkins RC
    Surgery; 1972 Jun; 71(6):857-64. PubMed ID: 5030502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.